James J Wu (Jim Wu, James Wu)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Cross Sectional

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

Journal of medical economics

Journal of comparative effectiveness research

This page only lists publications with an associated author ORCID identifier.

Publications

James J Wu, Sally W Wade, Taha Itani, Jean-Gabriel Castaigne, Ioana Kloos, Weimin Peng, Steve Kanters, Michael James Zoratti, Martin Dreyling, Bijal Shah, Michael Wang
Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis. Leukemia & lymphoma (2024)
James J Wu, Sally W Wade, Taha Itani, Jean-Gabriel Castaigne, Ioana Kloos, Weimin Peng, Steve Kanters, Michael James Zoratti, Martin Dreyling, Bijal Shah, Michael Wang
Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis. Leukemia & lymphoma (2024)
Svenja Petersohn, Gilles Andre Salles, Michael L Wang, James J Wu, Sally W Wade, Claire L Simons, Craig Bennison, Rubina Siddiqi, Weimin Peng, Ioana Kloos, Gab Castaigne, Georg Hess
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England. Journal of medical economics 25 (1) (2022)
Ashley Jaksa, James J Wu, Pall Jonsson, Hans-Georg Eichler, Sarah E Vititoe, Nicolle M Gatto
Organized structure of real-world evidence best practices: moving from fragmented recommendations to comprehensive guidance. Journal of comparative effectiveness research 10 (9) (2021)